NICHOLS ADVANTAGE CHEMILUMINESCENCE INTACT PARATHYROID HORMONE, MODEL 62-7022

Radioimmunoassay, Parathyroid Hormone

NICHOLS INSTITUTE DIAGNOSTICS

The following data is part of a premarket notification filed by Nichols Institute Diagnostics with the FDA for Nichols Advantage Chemiluminescence Intact Parathyroid Hormone, Model 62-7022.

Pre-market Notification Details

Device IDK040813
510k NumberK040813
Device Name:NICHOLS ADVANTAGE CHEMILUMINESCENCE INTACT PARATHYROID HORMONE, MODEL 62-7022
ClassificationRadioimmunoassay, Parathyroid Hormone
Applicant NICHOLS INSTITUTE DIAGNOSTICS 1311 CALLE BATIDO San Clemente,  CA  92673
ContactJimmy Wong
CorrespondentJimmy Wong
NICHOLS INSTITUTE DIAGNOSTICS 1311 CALLE BATIDO San Clemente,  CA  92673
Product CodeCEW  
CFR Regulation Number862.1545 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2004-03-30
Decision Date2004-06-08
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.